- Home
- EL vs MRNA Comparison
EL vs MRNA Comparison
Compare EL & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EL | MRNA |
|---|---|---|
| Founded | 1946 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.3B | 26.7B |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | EL | MRNA |
|---|---|---|
| Price | $83.05 | $55.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 12 |
| Target Price | ★ $97.60 | $34.27 |
| AVG Volume (30 Days) | 2.3M | ★ 6.5M |
| Earning Date | 05-01-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | N/A | ★ 21.77 |
| EPS | ★ 0.82 | N/A |
| Revenue | $14,326,000,000.00 | ★ $19,263,000,000.00 |
| Revenue This Year | $7.51 | $9.36 |
| Revenue Next Year | $4.08 | $15.43 |
| P/E Ratio | $97.91 | ★ N/A |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $66.22 | $22.28 |
| 52 Week High | $121.64 | $85.60 |
Technical Indicators
Market Signals| Indicator | EL | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 49.53 | 39.88 |
| Support Level | $80.76 | $45.69 |
| Resistance Level | $87.57 | $59.52 |
| Average True Range (ATR) | 2.34 | 3.53 |
| MACD | -0.05 | -2.33 |
| Stochastic Oscillator | 57.92 | 7.40 |
Price Performance
Historical ComparisonAbout EL Estee Lauder Companies Inc. (The)
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top-selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.